Medroxyprogesterone Acetate
Product Images NDC 0548-5410

Product Visual Gallery

This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Medroxyprogesterone Acetate (NDC 0548-5410). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Amphastar Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton-stock 5411-25-pack (25 Pack Vial Carton)

Medroxyprogesterone Acetate Injectable Suspension, USP 150 mg (150 mg/mL) labeled for intramuscular use in 25 x 1 mL single-dose vials. The label indicates it is manufactured by Amphastar Pharmaceuticals, Inc., Rancho Cucamonga, CA, and includes storage instructions and composition details with preservatives listed.*

FDA Label Image

Figure1 (Figure1)

A forest plot chart showing risk estimates for breast cancer in users of Medroxyprogesterone Acetate (DMPA). The chart displays odds ratios with 95% confidence intervals on a logarithmic scale from multiple studies, illustrating varied risk levels across different research sources.*

FDA Label Image

Chemical Structure (Medroxyprogesterone 01)

Chemical structure of Medroxyprogesterone Acetate showing its steroidal core with ketone and acetate functional groups.*

FDA Label Image

Figure 1 (Medroxyprogesterone 02)

An instructional illustration showing a hand holding a syringe, demonstrating the process of removing or attaching a needle or cap. The image focuses on the technique of handling the syringe tip with one hand while rotating the needle or cap with the other hand.*

FDA Label Image

Figure 2 (Medroxyprogesterone 03)

An instructional diagram showing a hand gripping a syringe with the needle pointing downward. The illustration is labeled as Figure 2 and appears to demonstrate proper syringe handling or injection technique for Medroxyprogesterone Acetate by Amphastar Pharmaceuticals, Inc.*

FDA Label Image

Chart (Medroxyprogesterone 04)

An illustration showing a vertical arrow labeled 'Fewer Pregnancies' at the top and 'More Pregnancies' at the bottom. Alongside the arrow are categories of pregnancy rates per 100 women per year, with corresponding contraceptive methods listed in boxes: 'Fewer than 1 pregnancy' includes implants, injections, intrauterine devices, and sterilization; 'Birth control pills, skin patch, vaginal ring with hormones' are also listed; 'Condons and diaphragm'; 'No sex during fertile days, spermicide, withdrawal'; and 'No birth control' corresponding to 85 or more pregnancies per 100 women per year.*

FDA Label Image

Novaplus1 (Novaplus1)

FDA Label Image

Novaplus2 (Novaplus2)

FDA Label Image

Carton-stock 5410 (Single Pack Vial Carton)

Medroxyprogesterone Acetate Injectable Suspension, USP, 150 mg per mL, packaging label from Amphastar Pharmaceuticals, Inc. The label indicates it is for intramuscular use only and contains a single 1 mL single-dose vial. The label includes active ingredients and storage instructions, as well as the novaplus logo and dosage information.*

FDA Label Image

Carton-stock 5711 (Syringe Carton)

Carton packaging label for Medroxyprogesterone Acetate Injectable Suspension, USP by Amphastar Pharmaceuticals, Inc. The label indicates a strength of 150 mg per 1 mL prefilled syringe. It is for intramuscular use only and includes storage and usage instructions along with assembly instructions for administration. The brand Novaplus is also mentioned on the label.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.